Abstract
Basaloid squamous cell carcinoma (BSCC), a histologically distinctive variant of squamous cell carcinoma comprising basal cell carcinoma and squamous cell carcinoma, is aggressive and shows a poor prognosis because of frequent lymph node invasion and distant metastases. To date few articles regarding chemotherapy for metastatic disease have been reported, thus feasible chemotherapy is not well established. Cetuximab is a monoclonal antibody for epithelial growth factor receptor (EGFR), which has great efficacy for head and neck squamous cell carcinoma due to EGFR signaling pathway blockage. Because BSCC also highly expresses EGFR, cetuximab may be effective for BSCC. We report here a first case of recurrent BSCC in the ethmoid sinus with intracranial extension treated with cetuximab-based chemotherapy, which revealed great response in a 40-year-old man. Positron emission tomography (PET) revealed no lymph node or distant metastasis. The patient underwent chemoradiotherapy 66 Gy in 33 fractions with triweekly 100 mg/m2 cisplatin. However, 12 weeks after treatment completion PET revealed a residual tumor at the primary cancer site. Combination therapy with weekly paclitaxel and cetuximab was started, and complete response was obs...Continue Reading
References
Sep 13, 2000·The Laryngoscope·A F PaulinoA G Huvos
Aug 19, 2004·ANZ Journal of Surgery·Michael JeffordIan D Davis
Dec 1, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Larry H KalishElizabeth A Musgrove
Jul 5, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kaisa ErjalaKlaus Elenius
Jun 2, 2007·Molecular Cancer Therapeutics·Barbara A FrederickDavid Raben
Jul 31, 2007·World Journal of Gastroenterology : WJG·Yoshihiro ShibataShuji Nakano
Apr 23, 2008·Cancer·Juliette ThariatAdam S Garden
Sep 12, 2008·The New England Journal of Medicine·Jan B VermorkenRicardo Hitt
Aug 15, 2009·Journal of the National Comprehensive Cancer Network : JNCCN·Barbara BurtnessSharon Spencer
Aug 26, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R HittUNKNOWN Spanish Head and Neck Cancer Cooperative Group (TTCC)
May 31, 2012·Anti-cancer Drugs·Julien PéronJérôme Fayette
Oct 3, 2012·Oral Oncology·Begoña JiménezEmilio Alba
Feb 6, 2013·PloS One·Hong-bing LiuYong Song
Aug 21, 2014·Critical Reviews in Oncology/hematology·Omar Abdel-Rahman, Mona Fouad
Oct 11, 2016·Auris, Nasus, Larynx·Satoshi KoyamaHiromi Takeuchi
Jun 9, 2017·Journal of Pathology and Translational Medicine·Kyung-Ja ChoSang Yoon Kim
Sep 25, 2017·Oral Oncology·Kenji NakanoShunji Takahashi